Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Naphthazarin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021 1 0
Ginkgolic acid C17:1 Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Sciadopitysin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Anacardic acid Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 2 0
Ginkgo biloba leaves extract Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021 1 0
Ambroxol Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021 2 0
Reduning Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021 1 0
Antipain Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0
Soybean Trypsin Inhibitor Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0
Trichostatin A Potential treatment - theoretical effect Natural product Antiviral Apr/10/2021 1 0